Figure 2.
ROR1 inhibition sensitizes BC cells to chemo drugs. (A) Immunoblot assessing efficacy of ROR1 knockdown via siRNA in MDA-MB-231 and SUM159PT. Full length blots are presented in the Supplementary Fig. S8. (B,C) MTT investigating cell viability following Dox/Cis treatment in both cell lines after either siROR1 or Control RNA transfection. (D,E) Fluorescence-based Annexin-V staining assay to assess apoptosis induction in both cell lines after treatment with Dox/Cis and/or StrC. (F) MTT investigating cell viability following Dox/Cis treatment in multidrug-resistant SUM159PT/R after either siROR1 or Control RNA transfection. Statistical analyses via student’s t test. N = 3. *p < 0.05.